Cimavas EGF, based on two proteins, triggers an immune response from the victim's body and has absolutely no side effects, as most anti-cancer therapy does. The vaccine only attacks cancer cells. The vaccine is meant to serve as a compliment to rather than a replacement for conventional methods such as chemotherapy and radiation. The vaccine also improves patients’ breathing and decreases their pain.